Evaluation of in-vitro activity of new quinolones, macrolides, and minocycline against Mycoplasma pneumoniae

スポンサーリンク

概要

• 論文の詳細を見る
• 2000-09-01

著者

• KAKU Mitsuo

  Department of Infection Control and Laboratory Diagnostics, Internal Medicine, Tohoku University Gra

• Yamamoto Hiroyuki

  Department of Cardiology, Kurashiki Central Hospital

• Yamamoto Hiroyuki

  Department Of Cardiology Kurashiki Central Hospital

• ISHIDA Kazuo

  Department of Microbiology, St. Marianna University School of Medicine

• Ishida Kazuo

  Department Of Animal Husbandry Faculty Of Agriculture Tohoku University:(present Address) Department

• IKEJIMA Hideaki

  Department of General Internal Medicine, St. Marianna University School of Medicine

• Kaku M

  Tohoku Univ. Graduate School Of Medicine Sendai Jpn

• Ikejima Hideaki

  Department Of Microbiology St. Marianna University School Of Medicine

• Ikejima Hideaki

  Department Of General Internal Medicine St. Marianna University School Of Medicine

• SHIMADA Jingoro

  Department of Microbiology, St Marianna University School

• ISHIDA Kazuo

  Institute of Medical Science, St. Marianna University School of Medicine

• Kaku Mitsuo

  Department Of Clinical And Laboratory Medicine Tohoku University Graduate School Of Medicine

• Shimada Jingoro

  Showa Pharmaceutical Univ. Tokuo Jpn

• Shimada Jingoro

  Department Of Microbiology And Medicine Division Of Clinical Pharmacology Institute Of Medical Scien

• Yamamoto H

  Graduate School Of Bioagricultural Science Nagoya University

• Ishida Kazuo

  Institute Of Medical Science St. Marianna University School Of Medicine

• Ishida Kazuo

  Departmenl Of Animal Husbandry Faculty Of Agriculture Tohoku University

• Yamamoto Hiroyuki

  Department Of Applied Biology Faculty Of Textile Science And Technology Shinshu University

• Shimada Jingoro

  Department Of Microbiology Showa Pharmaceutical University

• Kaku Mitsuo

  Department Of Infection Control And Laboratory Diagnostics Tohoku University Graduate School Of Medi

• Kaku Mitsuo

  Department Of Infection Control And Laboratory Diagnostics Tohoku University Graduate School Of Medi

• SHIMADA Jingoro

  Department of Internal Medicine, Jikei University School of Medicine

関連論文

• Cryptococcus neoformans inhibits nitric oxide synthesis caused by CpG-oligodeoxynucleotide-stimulated macrophages in a fashion independent of capsular polysaccharides
• 196) 当科における心肺蘇生後の低体温療法の成績(第92回日本循環器学会中国・四国合同地方会)
• 181) 下肢深部静脈血栓症から静脈破裂を来した1症例(第92回日本循環器学会中国・四国合同地方会)
• 125) PES (TAXUS) stentにおけるstent fractureに関して(第92回日本循環器学会中国・四国合同地方会)
• 98) 先天性心疾患に合併した心房頻拍の一例(第92回日本循環器学会中国・四国合同地方会)
• 9) 当院におけるシロリムス溶出性ステント(SES)留置症例におけるステント血栓症(ST)の検討(第92回日本循環器学会中国・四国合同地方会)
• 2) Bare Metal Stent種類別のlate lossの検討(第92回日本循環器学会中国・四国合同地方会)
• 147) ステント留置術後の核医学検査の有用性について(第92回日本循環器学会中国・四国合同地方会)
• Characterization of an Extended-Spectrum β-Lactamase from Escherichia coli Mediated by a Plasmid
• Successful Treatment of Primary Cardiac Lymphoma With Atrioventricular Nodal Block
• PJ-762 The Ratio and Lesion Morphology of Recurrent Restenosis after Reimplantation with Sirolimus-eluting Stent for Restenosis after Sirolimus-eluting Stent Implantation(PJ128,Coronary Revascularization, PCI (DES) 5 (IHD),Poster Session (Japanese),The 73
• PJ-478 The Detection of Cancer with Multidetecter Computed Tomography Coronary Angiography(PJ081,CT/MRI (Coronary/Vascular) 3 (I),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• PJ-408 Sirolimus-eluting Stent Implantation for In-stent Restenosis of Bare Metal Stent or Sirolimus-eluting Stent(PJ069,Coronary Revascularization, PCI (Restenosis/Others) 1 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japane
• PE-379 Late Restenosis of Sirolimus Eluting Stent Implantation in Chronic Total Occlusions(PE064,Coronary Revascularization, PCI (DES) 6 (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Society)
• PE-280 Unique Distribution of Stent Fracture and Stent Fracture with Restenosis after Sirolimus-Eluting Stent Implantation(PE047,Coronary Revascularization, PCI (DES) 4 (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circ
• PE-134 Is Previous Angiography as Follow up Useful to Predict Very Late Stent Thrombosis?(PE023,Coronary Revascularization, PCI (DES) 3 (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• OJ-255 Usefulness of Stress Myocardial Perfusion Imaging (MPI) in Detecting Significant Coronary Artery Stenosis in Multidetector Row Computed Tomography (MDCT) Era(OJ43,Nuclear Cardiology (Coronary, Myocardium) (I),Oral Presentation (Japanese),The 73rd A
• OJ-121 Predictors of Recurrent Restenosis after Treatment of Bifurcation Lesions with the Two-stent Strategy(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Cir
• OE-403 Stent Fracture and Stent Thrombosis after Sirolimus-eluting Stent Implantation(OE68,Coronary Revascularization, PCI (Restenosis/Others) 4 (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• OE-188 Prevalence and Predictors of Early and Late Restenosis after Sirolimus-Eluting Stent Implantation for de novo Lesion(OE32,Coronary Revascularization, PCI (Restenosis/Others) 2 (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting of
• PJ-657 Optimal Strategy of Restenosis with Stent Fracture after Sirolimus-eluting stent Implantation(Coronary revascularization, PCI(24)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-258 The 2-year Follow-up Results of Drug Eluting Stent Implantation for the de novo Unprotected Left Main Coronary Artery Disease.(Coronary revascularization, PCI(19)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circ
• PE-049 The Long-Term Predictors of Restenosis and Target-Lesion-Revascularization after Drug-Eluting-Stent Implantation for the de novo Unprotected Left Main Coronary Artery Disease.(Coronary revascularization, PCI(07)(IHD),Poster Session(English),The 72n
• OJ-221 Late Luminal Response after Stenting in Chronic Total Occlusions : A Comparison between Bare Metal Stent and Sirolimus-Eluting Stent Implantation(Restenosis basic / clinical(02)(IHD),Oral Presentation (Japanese),The 72nd Annual Scientific Meeting o
• OE-004 Late Restenosis After Sirolimus-eluting Stent Implantation : The Impact of Lesion Complexity(Coronary revascularization, PCI(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• FRS-025 Middle-term angiographic follow-up of BioMatrix^ stent implantation for left main to left anterior descending artery(Forefront Updates in PCI(01)(IHD),Featured Research Session,The 72nd Annual Scientific Meeting of the Japanese Circulation Soc
• PJ-744 Long-term Outcome of Treatment of De Novo Right Coronary Artery Ostial Lesions, Comparison with Drug-eluting Stents and Bare Metal Stents(Coronary revascularization, PCI-20, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-601 Prevalence of Side Effects of Clopidgrel Which was Prescribed to the Patients who Discontinued Ticlopidine due to its Side Effects(Coronary revascularization, PCI-16, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-266 The Angiographical Findings of the Late Restenosis : Comparison Between SES AND BMS Lesions(Restenosis basic/clinical-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• PE-485 Clinical Outcomes in Chronic Hemodialysis Patients : Initial and One-Year Follow-Up Results of the j-CYPHER Registry(Coronary revascularization, PCI-10, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• 重症くも膜下出血における急性期 CT perfusion による予後予測
• 2.救命救急におけるマルチスライスCTの有用性と今後の課題(救命救急における画像診断および治療技術の現状と課題,第63回総会学術大会シンポジウム)
• 心臓CTにおけるMulti PhaseECG Dose : Modulationの臨床検討(第64回総会学術大会放射線防護・管理関連演題発表後抄録)
• Measurement of (1-3)-β-D-Glucan Derived From Different Gauze Types
• PJ-762 The Ratio and Lesion Morphology of Recurrent Restenosis after Reimplantation with Sirolimus-eluting Stent for Restenosis after Sirolimus-eluting Stent Implantation(PJ128,Coronary Revascularization, PCI (DES) 5 (IHD),Poster Session (Japanese),The 73
• PJ-408 Sirolimus-eluting Stent Implantation for In-stent Restenosis of Bare Metal Stent or Sirolimus-eluting Stent(PJ069,Coronary Revascularization, PCI (Restenosis/Others) 1 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japane
• PE-280 Unique Distribution of Stent Fracture and Stent Fracture with Restenosis after Sirolimus-Eluting Stent Implantation(PE047,Coronary Revascularization, PCI (DES) 4 (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circ
• OJ-255 Usefulness of Stress Myocardial Perfusion Imaging (MPI) in Detecting Significant Coronary Artery Stenosis in Multidetector Row Computed Tomography (MDCT) Era(OJ43,Nuclear Cardiology (Coronary, Myocardium) (I),Oral Presentation (Japanese),The 73rd A
• OJ-121 Predictors of Recurrent Restenosis after Treatment of Bifurcation Lesions with the Two-stent Strategy(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Cir
• OE-188 Prevalence and Predictors of Early and Late Restenosis after Sirolimus-Eluting Stent Implantation for de novo Lesion(OE32,Coronary Revascularization, PCI (Restenosis/Others) 2 (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting of
• PJ-258 The 2-year Follow-up Results of Drug Eluting Stent Implantation for the de novo Unprotected Left Main Coronary Artery Disease.(Coronary revascularization, PCI(19)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circ
• PE-049 The Long-Term Predictors of Restenosis and Target-Lesion-Revascularization after Drug-Eluting-Stent Implantation for the de novo Unprotected Left Main Coronary Artery Disease.(Coronary revascularization, PCI(07)(IHD),Poster Session(English),The 72n
• FRS-025 Middle-term angiographic follow-up of BioMatrix^ stent implantation for left main to left anterior descending artery(Forefront Updates in PCI(01)(IHD),Featured Research Session,The 72nd Annual Scientific Meeting of the Japanese Circulation Soc
• Increased Expression of Insulin-Like Growth Factor I is Associated with Ara-C Resistance in Leukemia
• Stanniocalcin-1 as a Novel Marker to Detect Minimal Residual Disease of Human Leukemia
• High Expression of YB-1 Gene in Erythroid Cells in Patients with Refractory Anemia
• 各種アミノ配糖体系抗菌薬の緑膿菌のプロテアーゼ及びエラスターゼ産生抑制効果に関する検討
• PJ-762 The Ratio and Lesion Morphology of Recurrent Restenosis after Reimplantation with Sirolimus-eluting Stent for Restenosis after Sirolimus-eluting Stent Implantation(PJ128,Coronary Revascularization, PCI (DES) 5 (IHD),Poster Session (Japanese),The 73
• PJ-408 Sirolimus-eluting Stent Implantation for In-stent Restenosis of Bare Metal Stent or Sirolimus-eluting Stent(PJ069,Coronary Revascularization, PCI (Restenosis/Others) 1 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japane
• PE-280 Unique Distribution of Stent Fracture and Stent Fracture with Restenosis after Sirolimus-Eluting Stent Implantation(PE047,Coronary Revascularization, PCI (DES) 4 (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circ
• OJ-255 Usefulness of Stress Myocardial Perfusion Imaging (MPI) in Detecting Significant Coronary Artery Stenosis in Multidetector Row Computed Tomography (MDCT) Era(OJ43,Nuclear Cardiology (Coronary, Myocardium) (I),Oral Presentation (Japanese),The 73rd A
• OJ-121 Predictors of Recurrent Restenosis after Treatment of Bifurcation Lesions with the Two-stent Strategy(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Cir
• OE-188 Prevalence and Predictors of Early and Late Restenosis after Sirolimus-Eluting Stent Implantation for de novo Lesion(OE32,Coronary Revascularization, PCI (Restenosis/Others) 2 (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting of
• PJ-258 The 2-year Follow-up Results of Drug Eluting Stent Implantation for the de novo Unprotected Left Main Coronary Artery Disease.(Coronary revascularization, PCI(19)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circ
• FRS-025 Middle-term angiographic follow-up of BioMatrix^ stent implantation for left main to left anterior descending artery(Forefront Updates in PCI(01)(IHD),Featured Research Session,The 72nd Annual Scientific Meeting of the Japanese Circulation Soc
• OJ-080 Middle Term Clinical and Angiographic Outcomes of BioMatrix^ Stent Implantation for Left Main Coronary Artery Stenosis(Coronary revascularization, PCI-05, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• OE-243 Predictors of Angiographic Stent Fracture and Stent Fracture with Restenosis after Sirolimus-eluting stent (SES) Implantation(Coronary revascularization, PCI-03, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-762 The Ratio and Lesion Morphology of Recurrent Restenosis after Reimplantation with Sirolimus-eluting Stent for Restenosis after Sirolimus-eluting Stent Implantation(PJ128,Coronary Revascularization, PCI (DES) 5 (IHD),Poster Session (Japanese),The 73
• PJ-408 Sirolimus-eluting Stent Implantation for In-stent Restenosis of Bare Metal Stent or Sirolimus-eluting Stent(PJ069,Coronary Revascularization, PCI (Restenosis/Others) 1 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japane
• PE-280 Unique Distribution of Stent Fracture and Stent Fracture with Restenosis after Sirolimus-Eluting Stent Implantation(PE047,Coronary Revascularization, PCI (DES) 4 (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circ
• OJ-255 Usefulness of Stress Myocardial Perfusion Imaging (MPI) in Detecting Significant Coronary Artery Stenosis in Multidetector Row Computed Tomography (MDCT) Era(OJ43,Nuclear Cardiology (Coronary, Myocardium) (I),Oral Presentation (Japanese),The 73rd A
• OJ-121 Predictors of Recurrent Restenosis after Treatment of Bifurcation Lesions with the Two-stent Strategy(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Cir
• OE-188 Prevalence and Predictors of Early and Late Restenosis after Sirolimus-Eluting Stent Implantation for de novo Lesion(OE32,Coronary Revascularization, PCI (Restenosis/Others) 2 (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting of
• PJ-258 The 2-year Follow-up Results of Drug Eluting Stent Implantation for the de novo Unprotected Left Main Coronary Artery Disease.(Coronary revascularization, PCI(19)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circ
• FRS-025 Middle-term angiographic follow-up of BioMatrix^ stent implantation for left main to left anterior descending artery(Forefront Updates in PCI(01)(IHD),Featured Research Session,The 72nd Annual Scientific Meeting of the Japanese Circulation Soc
• PJ-762 The Ratio and Lesion Morphology of Recurrent Restenosis after Reimplantation with Sirolimus-eluting Stent for Restenosis after Sirolimus-eluting Stent Implantation(PJ128,Coronary Revascularization, PCI (DES) 5 (IHD),Poster Session (Japanese),The 73
• PJ-408 Sirolimus-eluting Stent Implantation for In-stent Restenosis of Bare Metal Stent or Sirolimus-eluting Stent(PJ069,Coronary Revascularization, PCI (Restenosis/Others) 1 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japane
• PE-280 Unique Distribution of Stent Fracture and Stent Fracture with Restenosis after Sirolimus-Eluting Stent Implantation(PE047,Coronary Revascularization, PCI (DES) 4 (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circ
• OJ-255 Usefulness of Stress Myocardial Perfusion Imaging (MPI) in Detecting Significant Coronary Artery Stenosis in Multidetector Row Computed Tomography (MDCT) Era(OJ43,Nuclear Cardiology (Coronary, Myocardium) (I),Oral Presentation (Japanese),The 73rd A
• OJ-121 Predictors of Recurrent Restenosis after Treatment of Bifurcation Lesions with the Two-stent Strategy(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Cir
• OE-188 Prevalence and Predictors of Early and Late Restenosis after Sirolimus-Eluting Stent Implantation for de novo Lesion(OE32,Coronary Revascularization, PCI (Restenosis/Others) 2 (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting of
• PJ-258 The 2-year Follow-up Results of Drug Eluting Stent Implantation for the de novo Unprotected Left Main Coronary Artery Disease.(Coronary revascularization, PCI(19)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circ
• FRS-025 Middle-term angiographic follow-up of BioMatrix^ stent implantation for left main to left anterior descending artery(Forefront Updates in PCI(01)(IHD),Featured Research Session,The 72nd Annual Scientific Meeting of the Japanese Circulation Soc
• Left Ventricular Reconstruction with or without Mitral Annuloplasty
• Impact of Subvalvular Procedure for Ischemic Mitral Regurgitation on Leaflet Configuration, Mobility, and Recurrence
• 5 Subvalvular Procedure for Ischemic Mitral Regurgitation improved Anterior Leaflet Configuration and Motion with Reduction of Recurrence(Symposium 9 (SY-09) (M) New Insight for Treatment of Ischemic Mitral Regurgitation,Special Program,The 72nd Annual Sc
• 5 Subvalvular Procedure for Ischemic Mitral Regurgitation improved Anterior Leaflet Configuration and Motion with Reduction of Recurrence(Symposium 9 (SY-09) (M) New Insight for Treatment of Ischemic Mitral Regurgitation,Special Program,The 72nd Annual Sc
• Comparison of Complement Fixation and Microimmunofluorescence Tests in Respiratory Infections Caused by Chlamydia and an Evaluation of the Serum Amyloid A Protein in Chlamydial Infections
• Clinical and Immunological Evaluation of Infection in Patients on Hemodialysis
• A Mutation of the Glucocorticoid Receptor Gene in Patients with Systemic Lupus Erythematosus
• Synergistic Effect of Arsenic Trioxide and Flt3 Inhibition on Cells with Flt3 Internal Tandem Duplication
• Induction of Erythroid-Specific Genes by Overexpression of GATA-2 in K562 Cells
• Purulent Pericarditis Due to Group B Streptococcus and Mycotic Aneurysm of the Ascending Aorta : Case Report
• Dectin-1 Is Not Required for the Host Defense to Cryptococcus neoformans
• Adjuvant Effect of CpG-Oligodeoxynucleotide in Anti-Fungal Chemotherapy against Fatal Infection with Cryptococcus neoformans in Mice
• Evaluation of hematuria using the urinary albumin-to-total-protein ratio to differentiate glomerular and nonglomerular bleeding
• マイコプラズマにおけるブレイクポイントの考え方
• Efficacy of Amikacin Combinations for Nocardiosis
• Antimicrobial activity of everninomicin against clinical isolates of Enterococcus spp., Staphylococcus spp., and Streptococcus spp. tested by Etest
• Comparison of in-vitro activities of SCH27899 and other antibiotics against Mycoplasma pneumoniae
• Characterization of MRSA transmission in an emergency medical center by sequence analysis of the 3'-end region of the coagulase gene
• Relatedness between the Coagulase Gene 3'-End Region and Coagulase Serotypes among Staphylococcus aureus Strains
• Evaluation of in-vitro activity of new quinolones, macrolides, and minocycline against Mycoplasma pneumoniae
• Monolayer Culture Systems with Respiratory Epithelial Cells for Evaluation of Bacterial Invasiveness
• Trends in Antimicrobial Susceptibility of Streptococcus pneumoniae in the Tohoku District of Japan : A Longitudinal Analysis from 1998 to 2007
• Experimental verification of the efficacy of optimized two-step infusion therapy with meropenem using an in vitro pharmacodynamic model and Monte Carlo simulation
• Delayed Recovery of Effector Memory CD4+ T Cells by Highly Active Antiretroviral Therapy in a Patient with HIV-1 Infection
• Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan
• Development of interpretive criteria for tebipenem disk diffusion susceptibility testing with Staphylococcus spp. and Haemophilus influenzae
• Methicillin resistant Staphylococcus aureus in a Japanese community hospital : 5-year experience

もっと見る 閉じる

スポンサーリンク